Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.
about
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Surgery of primary melanomas.Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma.Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.A new understanding in the epidemiology of melanomaAcral lentiginous melanoma: a case control study and guidelines update.Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanomaA high proliferative index of recurrent melanoma is associated with worse survivalFuture of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma.Analysis of skin lesions using laminar optical tomography.Surgery and sentinel lymph node biopsyWide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma.Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.Malignant melanoma of the head and neck: a brief review of pathophysiology, current staging, and management.Surgical management of melanoma: an EORTC Melanoma Group survey.Mechanisms of CXCR7 induction in malignant melanoma development.Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
P2860
Q26770492-BE034E3C-88C9-43C8-8C85-1765322C6BCEQ30356095-8494C4D9-C4A4-4AD9-9B81-5307A0C58CC7Q30669529-DD8178A1-B0F6-4E88-A281-EF1EF46D9A7CQ33196030-A6F4B548-6669-4F36-BA3F-33BE4F697574Q33651716-BAFAC12C-6481-4796-9FDD-8F8B154C303CQ33717075-FFE5E4DA-5039-43B8-850D-E56EFA763E1FQ33880905-C70443FE-3F62-4D56-BA80-8B1135169F6AQ34000266-24BFCFD6-64C7-4521-8E0F-1D5F669DAB20Q34625205-BC405B9C-C5BA-4E14-B4A1-4966BFCF3A35Q34898020-AFCD1A6E-431B-4BE8-826A-1E6B864097C5Q35016267-F6900D09-F7DC-4490-97D2-D9EE5F0E32A6Q35089965-305BE2FA-81A2-445B-9552-F08B4960A813Q35221682-0CCE2DCF-3227-4F10-84E1-495951BE8E7BQ35747918-4A608BBD-C1AA-4B4E-A51A-276543D80684Q36061606-2D8F2D66-9010-44E1-A6F7-767FC32A0C95Q36091513-52545BF5-43C5-438E-BD36-C2D6B5B9BB35Q36393331-6160253F-A109-4FE9-BE92-3A3DFE7D836BQ36534799-9D36A25C-592D-405E-90C8-DD477CF6DC4EQ36916654-22C0E0B5-6211-4569-9794-5BAACDB1222AQ36997182-A5A0EA6D-CE66-4C5C-B7F3-805BB9E72CF5Q37148943-C4003AE0-0995-4B76-88C6-49D45C8A8500Q37548776-C7812BE8-0366-4E75-B519-3C8AE62F908CQ37878331-3859A3BF-FB92-4A9F-90B9-25C47B01B0FDQ39743860-994E7EBC-6A99-44FB-95B4-2509DBAADB5EQ41388747-3723AB3D-1076-47FB-9AB2-B857511C43F4Q55619003-0CC92BF1-3C08-49E5-930A-99090E91B8D0Q57797941-699223DE-83B1-4C90-BF03-160BBAF55531
P2860
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@ast
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@en
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@nl
type
label
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@ast
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@en
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@nl
prefLabel
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@ast
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@en
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@nl
P2093
P1476
Long-term results of a prospec ...... atients with 1-4 mm melanomas.
@en
P2093
C P Karakousis
H J Wanebo
Investigators from the Intergroup Melanoma Surgical Trial
R L Barnhill
P2888
P304
P356
10.1007/S10434-001-0101-X
P577
2001-03-01T00:00:00Z